Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of E7080 in Patients With Advanced Hepatocellular Carcinoma (HCC)

NCT00946153 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT00946153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00946153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of E7080 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
July 24, 2009
Completion date
August 13, 2015
Enrollment
66 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma